Daily Archives: September 16, 2020

Lithium Werks ยกระดับหน่วยธุรกิจด้านการแพทย์และการดูแลสุขภาพ

Lithium Werks, B.V. ประกาศการจัดตั้งหน่วยธุรกิจด้านการแพทย์และการดูแลสุขภาพใหม่ที่จะมุ่งเน้นการมอบพลังงานแบบพกพา โซลูชันพลังงานและผลิตภัณฑ์ที่จะช่วยต่อสู้กับไวรัสและลดจำนวนผู้ติดเชื้อ

ออสติน, เท็กซัสและเอ็นสเคอเด, เนเธอร์แลนด์, Sept. 16, 2020 (GLOBE NEWSWIRE) — Lithium Werks ได้ใช้ประโยชน์จากการเข้าซื้อกิจการของ A123 Industrial Division และ Valence Technology โดยจัดตั้งหน่วยธุรกิจด้านการแพทย์ที่ได้รับการปรับปรุงเพื่อเป็นพันธมิตรและทำงานร่วมกับ OEM อุปกรณ์ทางการแพทย์และผู้รวมระบบทางการแพทย์ รวมถึงบริษัทด้านการดูแลสุขภาพและชุมชนต่างๆ เพื่อส่งมอบพลังงานลิเธียมแบบพกพาและโซลูชันพลังงานเพื่อช่วยต่อสู้กับไวรัสและลดจำนวนผู้ติดเชื้อ

Lithium Werks ยินดีที่จะแบ่งปันหน่วยธุรกิจใหม่นี้ด้วยความมุ่งมั่นที่จะพัฒนาห่วงโซ่อุปทานด้านแบตเตอรี่ลิเธียมทางการแพทย์จากแบตเตอรี่รถเข็นการแพทย์ เตียงโรงพยาบาล อุปกรณ์ผ่าตัด เครื่องกระตุ้นหัวใจ รวมทั้งแบตเตอรี่แบบพกพาสำหรับเครื่องช่วยหายใจและอุปกรณ์ป้องกันทางเดินหายใจ โดยใช้ประโยชน์จากเซลล์ลิเธียมระดับโลก โมดูลแบตเตอรี่ ระบบการจัดการแบตเตอรี่ รวมถึง Nanophosphate® ที่พัฒนาโดย MIT ซึ่งเป็นที่รู้จักในชื่อ Power.Safety.Life. และยังรวมถึงหุ่นยนต์, อุปกรณ์ทำความสะอาด UV และอุปกรณ์ฆ่าเชื้อ, อุปกรณ์จัดเก็บพลังงาน, พลังงานสำรองและแหล่งพลังงานสำรอง

Lithium Werks ได้จำหน่ายเซลล์และโมดูลแบตเตอรี่ไปแล้วกว่า 100 ล้านเหรียญสหรัฐฯ ในช่วงทศวรรษที่ผ่านมาให้กับวงการแพทย์ บริษัทได้สร้างกลุ่มผลิตภัณฑ์ OEM ทางการแพทย์ระดับโลกและลูกค้าผู้รวมระบบการดูแลสุขภาพ และขณะนี้กำลังพัฒนาผลิตภัณฑ์ที่หลากหลายสำหรับการจัดเก็บพลังงาน หุ่นยนต์ และการใช้งานในอุตสาหกรรมที่สนับสนุนอุตสาหกรรมด้านการดูแลสุขภาพ John Aittama ประธานเจ้าหน้าที่ฝ่ายปฏิบัติการได้กล่าวว่า “Lithium Werks ได้พัฒนาความโดดเด่นในด้านอุปกรณ์ทางการแพทย์มากว่า 10 ปีและอยู่ในตำแหน่งที่ดีในการสร้างประวัติอันยาวนานด้านคุณภาพและความน่าเชื่อถือ”

เนื่องจากการระบาดใหญ่ได้ยกระดับความกังวลด้านสุขภาพและความปลอดภัย Lithium Werks จึงได้ดำเนินการในส่วนของพวกเขาเพื่อต่อสู้กับการแพร่กระจายของไวรัสโควิด-19 และปัญหาสุขภาพอื่นๆ อีกมากมายโดยการเพิ่มการมุ่งเน้นและการทำงานร่วมกันเพื่อช่วยสนับสนุนโรงพยาบาล, บุคลากรทางการแพทย์, ผู้ป่วย, OEM ทางการแพทย์ และผู้รวมระบบการแพทย์ Don Lenz รองประธานฝ่ายขายระดับโลกยืนยันว่า “การเตรียมพร้อมให้กับพนักงานแถวหน้าที่กล้าหาญของเราในการรับมือการระบาดทั่วโลกนี้ด้วยหน่วยการจัดเก็บพลังงานลิเธียมที่ใช้งานได้ยาวนานและชาร์จได้รวดเร็วช่วยให้ผู้เชี่ยวชาญด้านการแพทย์การ ดับเพลิง และตำรวจพร้อมอยู่เสมอเพื่อช่วยเหลือผู้ป่วยที่เปราะบางที่สุด”

ไม่ว่าความต้องการด้านพลังงานทางการแพทย์แบบพกพาของคุณเป็นอย่างไร โปรดติดต่อ Lithium Werks สำหรับโซลูชันแบตเตอรี่ลิเธียมระดับมืออาชีพ

สำหรับข้อมูลเพิ่มเติม โปรดติดต่อเราที่ https://lithiumwerks.com/contact/

เกี่ยวกับ Lithium Werks – Lithium Werks ก่อตั้งในปี 2017 และได้รวมความเป็นผู้นำของโลกด้านวัสดุลิเธียมไอออนฟอสเฟต เซลล์ โมดูล และระบบการจัดการแบตเตอรี่ไว้ด้วยกันอย่างค่อยเป็นค่อยไป เป็นหนึ่งในบริษัทแบตเตอรี่ลิเธียมไอออนที่เติบโตเร็วที่สุดในโลก และเป็นผู้นำระดับโลกด้านสิทธิบัตรและผลิตภัณฑ์ LFP โดยมีการดำเนินงานในประเทศจีน ยุโรป และสหรัฐอเมริกา สำหรับข้อมูลเพิ่มเติมเกี่ยวกับ Lithium Werks โปรดไปที่ www.lithiumwerks.com

ติดต่อ:
lwmarketing@lithiumwerks.com

Bombardier and Alstom Sign Definitive Agreement for Sale of Transportation Business

  • Sale based on enterprise value of $8.4 billion (EUR 7.15B), reflecting a post-MOU $350M (€300M) price reduction, offset by positive foreign currency impact
  • Net proceeds to Bombardier expected to be ~$4.0B at closing
  • Closing now expected in the first quarter of 2021, subject to customary closing conditions and remaining regulatory approvals

All amounts in this press release are in U.S. dollars unless otherwise indicated. Amounts in EUR in this press release are converted to USD at an approximate 1:1.17 exchange rate.

MONTREAL, Sept. 16, 2020 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) today announced that it has signed a definitive Sale and Purchase Agreement (SPA), with Alstom SA and the Caisse de dépôt et placement du Québec (“la Caisse”) for the sale of its Transportation business to Alstom.

Under the SPA, Bombardier and la Caisse will sell their interests in Bombardier Transportation to Alstom on the basis of an enterprise value of $8.4 billion (EUR 7.15B), reflecting a $350M (EUR 300M) price reduction from the previously announced Memorandum of Understanding (MOU), offset by the impact of a more favourable currency exchange rate.

Based on Bombardier Transportation’s current operational performance and market conditions, total proceeds after the deduction of debt-like items, transferred liabilities and estimated closing adjustments1 are expected to be $6.2B, based on the lower end of the range agreed to in the SPA. After deducting la Caisse’s equity position of $2.2B billion, Bombardier expects net proceeds of ~ $4.0B2.  This amount includes $585M (EUR 500M) of Alstom shares for a fixed subscription price of EUR 47.50 per share, monetizable after a three-month lock-up post-closing.

“Today’s announcement marks a significant milestone towards achieving our near-term priorities and repositioning Bombardier as a pure-play business jet company,” said Éric Martel, President and Chief Executive Officer, Bombardier Inc. “The proceeds from this transaction will allow us to begin reshaping our capital structure and start addressing our balance sheet through debt paydown, so that we can achieve the full potential of our incredibly talented employees and our industry leading business jet portfolio.”

The signing of the SPA follows the completion of the required works council consultations. With regulatory approvals obtained from several jurisdictions, including the European Commission, the transaction closing is now expected in the first quarter of 2021, subject to the completion of the remaining regulatory reviews and other customary closing conditions, as well as Alstom shareholders’ approval at the company’s upcoming October 29, 2020 Extraordinary Shareholders’ Meeting.

About Bombardier
With nearly 60,000 employees across two business segments, Bombardier is a global leader in the transportation industry, creating innovative and game-changing planes and trains. Our products and services provide world-class transportation experiences that set new standards in passenger comfort, energy efficiency, reliability and safety.

Headquartered in Montréal, Canada, Bombardier has production and engineering sites in over 25 countries across the segments of Aviation and Transportation. Bombardier shares are traded on the Toronto Stock Exchange (BBD). In the fiscal year ended December 31, 2019, Bombardier posted revenues of $15.8 billion. News and information are available at bombardier.com or follow us on Twitter @Bombardier.

1 Includes the impact from obligations related to achieving a minimum cash balance at Bombardier Transportation at the end of 2020.
2 While the SPA is based on EUR currency, the parties have agreed that net cash proceeds to Bombardier will be paid in USD at the current €/USD exchange rate.

Bombardier is a trademark of Bombardier Inc. or its subsidiaries.

For information

Jessica McDonald Patrick Ghoche
Advisor, Media Relations and Public Affairs Vice President, Corporate Strategy and Investor Relations
Bombardier Inc. Bombardier Inc.
+514 861 9481 +514 861 5727
jessica.mcdonald@bombardier.com

FORWARD-LOOKING STATEMENTS

This press release includes forward-looking statements, which may involve, but are not limited to: statements with respect to our objectives, anticipations and outlook or guidance in respect of various financial and global metrics and sources of contribution thereto, targets, goals, priorities, market and strategies, financial position, market position, capabilities, competitive strengths, credit ratings, beliefs, prospects, plans, expectations, anticipations, estimates and intentions; general economic and business outlook, prospects and trends of an industry; expected demand for products and services; growth strategy; product development, including projected design, characteristics, capacity or performance; expected or scheduled entry-into-service of products and services, orders, deliveries, testing, lead times, certifications and project execution in general; competitive position; expectations regarding challenging Transportation projects and the release of working capital therefrom; expectations regarding revenue and backlog mix; the expected impact of the legislative and regulatory environment and legal proceedings; strength of capital profile and balance sheet, creditworthiness, available liquidities and capital resources and expected financial requirements; productivity enhancements, operational efficiencies and restructuring initiatives; expectations and objectives regarding debt repayments and refinancing of bank facilities and maturities; expectations regarding availability of government assistance programs, compliance with restrictive debt covenants; expectations regarding the declaration and payment of dividends on our preferred shares; intentions and objectives for our programs, assets and operations;  and the impact of the COVID-19 pandemic on the foregoing and the effectiveness of plans and measures we have implemented in response thereto. As it relates to the transaction discussed herein, this press release also contains forward-looking statements with respect to: the expected terms, conditions, and timing for completion thereof; the anticipated proceeds and use thereof and/or consideration therefor, as well as the anticipated benefits of such transaction and their expected impact on our outlook, guidance and targets, operations, infrastructure, opportunities, financial condition and cash on hand, business plan and overall strategy (including our expectation of a deleveraged profile and reshaped capital structure and the retiring of la Caisse’s preferred equity in Transportation); and the fact that closing of this transaction will be conditioned on certain events occurring, including without limitation the receipt of necessary regulatory approvals and receipt of Alstom shareholder approval in respect of the required capital increase.

Forward-looking statements can generally be identified by the use of forward-looking terminology such as “may”, “will”, “shall”, “can”, “expect”, “estimate”, “intend”, “anticipate”, “plan”, “foresee”, “believe”, “continue”, “maintain” or “align”, the negative of these terms, variations of them or similar terminology. Forward-looking statements are presented for the purpose of assisting investors and others in understanding certain key elements of our current objectives, strategic priorities, expectations, outlook and plans, and in obtaining a better understanding of our business and anticipated operating environment. Readers are cautioned that such information may not be appropriate for other purposes.

By their nature, forward-looking statements require management to make assumptions and are subject to important known and unknown risks and uncertainties, which may cause our actual results in future periods to differ materially from forecast results set forth in forward-looking statements. While management considers these assumptions to be reasonable and appropriate based on information currently available, there is risk that they may not be accurate. The assumptions underlying the forward-looking statements made in this press release in relation to the transaction discussed herein include the following material assumptions: the satisfaction of all closing conditions (including without limitation receipt of regulatory approvals on acceptable terms within commonly experienced time frames and receipt of Alstom shareholder approval in respect of the required capital increase) and successful completion of such transaction within the anticipated timeframe, the realization of the intended benefits therefrom (including receipt of expected proceeds and intended use thereof) within the anticipated timeframe; our ability to retain key management and employees during the pendency and following completion of the transaction; our ability to satisfy our liabilities and meet our financial covenants and debt service obligations during the pendency and following completion of the transaction; our ability to access the capital markets as needed during the pendency and following completion of the transaction; and fulfillment by the other parties of their respective obligations, commitments and undertakings pursuant to transaction documentation. For additional information, including with respect to the other assumptions underlying the forward-looking statements made in this press release, refer to the assumptions below the Forward-looking statements in the MD&A of our financial report for the three-and six-month periods ended June 30, 2020 and the Strategic Priorities and Guidance and forward-looking statements sections in the applicable reportable segment in the MD&A of our financial report for the fiscal year ended December 31, 2019. Given the impact of the changing circumstances surrounding the COVID-19 pandemic and the related response from Bombardier, governments (federal, provincial and municipal), regulatory authorities, businesses and customers, there is inherently more uncertainty associated with our assumptions as compared to prior periods.

Certain factors that could cause actual results to differ materially from those anticipated in the forward-looking statements include, but are not limited to, risks associated with general economic conditions, risks associated with our business environment (such as risks associated with “Brexit”, the financial condition of the airline industry, business aircraft customers, and the rail industry; trade policy; increased competition; political instability and force majeure events or global climate change), operational risks (such as risks related to developing new products and services; development of new business and awarding of new contracts; book-to-bill ratio and order backlog; the certification and homologation of products and services; fixed-price and fixed-term commitments and production and project execution, including challenges associated with certain Transportation projects; pressures on cash flows and capital expenditures based on project-cycle fluctuations and seasonality; execution of our strategy, transformation plan, productivity enhancements, operational efficiencies and restructuring initiatives; doing business with partners; inadequacy of cash planning and management and project funding; product performance warranty and casualty claim losses; regulatory and legal proceedings; environmental, health and safety risks; dependence on certain customers, contracts and suppliers; supply chain risks; human resources; reliance on information systems; reliance on and protection of intellectual property rights; reputation risks; risk management; tax matters; and adequacy of insurance coverage), financing risks (such as risks related to liquidity and access to capital markets; retirement benefit plan risk; exposure to credit risk; substantial debt and interest payment requirements; restrictive debt covenants and minimum cash levels; financing support for the benefit of certain customers; and reliance on government support), market risks (such as foreign currency fluctuations; changing interest rates; decreases in residual values; increases in commodity prices; and inflation rate fluctuations). For more details, see the Risks and uncertainties section in Other in the MD&A of our financial report for the fiscal year ended December 31, 2019. Any one or more of the foregoing factors may be exacerbated by the growing COVID-19 outbreak and may have a significantly more severe impact on our business, results of operations and financial condition than in the absence of such outbreak. As a result of the current COVID-19 pandemic, additional factors that could cause actual results to differ materially from those anticipated in the forward-looking statements include, but are not limited to: risks related to the impact and effects of the COVID-19 pandemic on economic conditions and financial markets and the resulting impact on our business, operations, capital resources, liquidity, financial condition, margins, prospects and results; uncertainty regarding the magnitude and length of economic disruption as a result of the COVID-19 outbreak and the resulting effects on the demand environment for our products and services; emergency measures and restrictions imposed by public health authorities or governments, fiscal and monetary policy responses by governments and financial institutions; disruptions to global supply chain, customers, workforce, counterparties and third-party service providers; further disruptions to operations, production, project execution and deliveries; technology, privacy, cyber security and reputational risks; and other unforeseen adverse events.

With respect to the transaction discussed herein specifically, certain factors that could cause actual results to differ materially from those anticipated in the forward-looking statements include, but are not limited to: the failure to receive or delay in receiving regulatory approvals on acceptable terms, the failure to receive or delay in receiving Alstom shareholder approval in respect of the required capital increase, the occurrence of a material adverse change, or otherwise satisfy the conditions to the completion of this transaction or delay in completing, and uncertainty regarding the length of time required to complete, such transaction, and all or part of the intended benefits therefrom not being realized and all or part of the anticipated proceeds therefrom not being available to us within the anticipated timeframe, or at all, or it is determined, necessary or required to direct all or part of the anticipated proceeds therefrom towards other uses than those identified in this press release; and alternate sources of funding to replace the anticipated proceeds from such transaction may not be available when needed, or on desirable terms; the occurrence of an event which would allow the parties to terminate their obligations, commitments and undertakings pursuant to transaction documentation; changes in the terms of the transaction; the failure by the parties to fulfill their obligations, commitments and undertakings pursuant to transaction documentation; Bombardier being unable to satisfy its liabilities and meet its financial covenants and debt service obligations during the pendency and following completion of the transaction; the failure to retain our key management, personnel and clients during the pendency and following completion of the transaction and risks associated with the loss and replacement of key management and personnel; and the impact of the announcement of the transaction on our relationships with third parties, including potentially resulting in the loss of clients, employees, suppliers, business partners or other benefits and goodwill of the business. There is no certainty, nor can we provide any assurance, that the conditions to closing of the proposed transaction will be satisfied or, if satisfied, when they will be satisfied. If the proposed transaction is not completed for any reason, there is a risk that the announcement of such transaction and the dedication of substantial resources of Bombardier to the completion thereof could have a negative impact on our operating results and business generally, and could have a material adverse effect on our current and future operations, financial condition and prospects, including the loss of investor confidence in connection with our ability to execute its strategic plan. In addition, failure to complete the proposed transaction for any reason could materially negatively impact the market price of our securities. If the proposed transaction is not completed for any reason, there can be no assurance that management will be successful in its efforts to identify and implement other strategic alternatives that would be in the best interests of Bombardier and its stakeholders within the context of existing market, regulatory and competitive conditions in the industries in which we operate, on favourable terms and timing or at all, and, if implemented, that such actions would have the planned results. We also have incurred significant transaction and related costs in connection with the proposed transaction, and additional significant or unanticipated costs may be incurred.

Readers are cautioned that the foregoing list of factors that may affect future growth, results and performance is not exhaustive and undue reliance should not be placed on forward-looking statements. For more details, see the Risks and uncertainties sections in Other in the MD&A of our financial report for the fiscal year ended December 31, 2019. Other risks and uncertainties not presently known to us or that we presently believe are not material could also cause actual results or events to differ materially from those expressed or implied in our forward-looking statements. The forward-looking statements set forth herein reflect management’s expectations as at the date of this press release and are subject to change after such date. Unless otherwise required by applicable securities laws, we expressly disclaim any intention, and assume no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Sun Genomics Announces Close of Series A Financing and Growth With New Talent and Scientific Advisor

Series A totals $9.25 million with new appointments of Dr. Jack Gilbert as Scientific Advisor and Mayank Goel as Vice President of Growth

SAN DIEGO, Sept. 16, 2020 (GLOBE NEWSWIRE) — Sun Genomics, the direct-to-consumer custom probiotics and gut health company, announced today the close of $9.25 million in Series A funding. The round was led by Pangaea Ventures with new investments from Orion Fund, managed by K3 Ventures, and Emerging Technologies Partners. Additional investors include Danone Manifesto Ventures, SOSV, Human Longevity, and Nascita Ventures.

“Among the scientific and general community, the awareness and understanding of the gut microflora’s important impact on a person’s overall health and well-being is growing rapidly,” said MX Kuok, managing partner of K3 Ventures. “We are proud to support Sun Genomics’ scientifically rigorous approach to microbiome sequencing and customized probiotics, which has already improved lives in a quantifiable, measurable way.”

K3 Ventures invests in early-stage and late-stage technology startups with companies such as Palantir, Airbnb, SpaceX, Planet Labs, and TikTok in its portfolio.

Sun Genomics will use this round of funding to support its growth in the custom probiotics market, scale delivery across the U.S., enter international markets, and propel the publication of its studies in partnership with leading academic institutions.

“Despite the many challenges and setbacks the pandemic has had on businesses and individuals, we’re proud of the momentum we’ve built this year from this new financing, to a prestigious academic collaboration, and the launch of our innovative immunity-health supplement, Floré Defense,” said Sunny Jain, CEO and founder of Sun Genomics.

In addition to the Series A close, Sun Genomics announces Dr. Jack Gilbert, PhD, as medical and scientific advisor, and Mayank Goel as vice president of growth.

  • At the University of California, San Diego Center of Microbiome Innovation, Dr. Gilbert uses molecular analysis to test fundamental hypotheses in microbial ecology. He has authored more than 250 peer-reviewed publications and book chapters on metagenomics and approaches to ecosystem ecology.
  • Prior to Sun Genomics, Goel led growth marketing and analytics at two successfully acquired travel startups – HotelTonight (acquired by Airbnb) and Pillow (acquired by Vrbo, Expedia Group). He has created data-driven personalized services leading to growing user retention and revenues. Goel brings a unique combination of growth strategy and data analytics to help Sun Genomics become the leader in custom probiotics.

Sun Genomics was founded in 2016 with the release of its flagship product Floré, a microbiome test and gut probiotics solution that utilizes whole-genome sequencing to evaluate different digestive system data points and ensure that customers receive a completely personalized product that is based on their unique gut profiles. As part of its growing line of gut health products, Sun Genomics launched Floré Defense in July 2020, an all-natural formula to boost immunity and respiratory health.

“I’m excited to work with the innovative leaders at Sun Genomics as they continue to study and educate consumers and companies on the ecology of the gut microbiome to improve overall health,” said Dr. Gilbert, medical and scientific advisor. “Gut testing will soon be standard of care for preventative health and I look forward to collaborating with Sun Genomics as they grow the production of scientifically credible solutions and research.”

About Sun Genomics
Sun Genomics is a first-of-its-kind, custom probiotics startup with the mission to improve gut health through personalized science. The company’s first consumer product, Floré, allows consumers to analyze the microflora of their stool and uses the results to craft a custom probiotic. Through DNA sequencing, Floré formulates the right probiotics for each customer’s specific needs and delivers it directly to their door. Sun Genomics has created the first feedback loop to allow customers to see their probiotics show up on their report, through a retest, and allows customers to improve their microflora over time. For more information, visit www.sungenomics.com or follow on Twitter: @SunGenomics.

Contact:
Emily Webb
SunGenomics@bamtheagency.com

Lithium Werks to Sell Nanophosphate Cathode Powder to Lithium Battery Producers

Lithium Werks, B.V., announces plans to start selling the world-renowned Nanophosphate® cathode powder for lithium batteries to lithium battery producers. Lithium Werks is also entertaining offers for licenses for its global portfolio of low-cost LFP manufacturing process patents.

AUSTIN, Texas and ENSCHEDE, The Netherlands, Sept. 16, 2020 (GLOBE NEWSWIRE) — Lithium Werks is pleased to announce that effective immediately, they are now selling their patented and proprietary, world leading Nanophosphate® powder. This technology was originally developed by MIT, and then first commercialized by A123 Systems, Inc. Lithium Werks has acquired rights to the game-changing, cobalt-free cathode material and is now willing to sell this leading LFP powder to lithium ion battery producers. While other battery companies are currently trying to reduce the amount of cobalt in their lithium ion batteries, Lithium Werks has succeeded in eliminating not only cobalt, but the expensive and heavy metal nickel. Nanophosphate® has been used and validated in over 10,000 hybrid electric buses on the road for millions of miles since 2014, as well as used in many other medical, industrial and energy storage products over the last decade.

“We are pleased to sell our Nanophosphate® cathode powder, the world’s premier Lithium Iron based Phosphate (LFP) powder. While other leading battery companies are trying to reduce the amount of cobalt in their lithium batteries, we have already achieved this,” says Joe Fisher, Co-Founder and CEO of Lithium Werks. “It is known globally for its Power.Safety.Life. and its lower total cost of ownership.”

Additionally, Lithium Werks is pleased to announce they are open to granting licenses of their LFP manufacturing process patents, which is a portfolio consisting of low-cost production methods to manufacture Lithium Iron Phosphate (LFP) cathode materials. It was originally invented and patented by Valence Technology, Inc. and was acquired by Lithium Werks, owner of the world’s largest patent portfolio of LFP materials and related technologies.

This patented process is universally recognized to be the most cost-effective method in manufacturing Lithium Iron Phosphate (LFP) cathode materials at scale. LFP is currently the world’s second most adopted cathode material for lithium ion batteries. It is particularly relevant today as it does not contain any cobalt, and is known globally for its power, safety and long cycle life versus other lithium-ion cathode materials.

“There is no Co or Ni in LFP,” says Lithium Werks CTO, Dr. Yazid Saidi, who is a holder of several of the patents around LFP technology. “These patents, together with the process patents, enable a unique route to scalable and cost-effective production of this game-changing cathode material.”

For more information on obtaining a license or purchasing Nanophosphate®, please contact us at: https://lithiumwerks.com/contact/

Lithium Werks has quietly put together the world’s leading position of Lithium Iron Phosphate materials, cells, modules and battery management systems. They are one of the world’s fastest growing lithium ion battery companies, and a global leader in LFP patents and products with operations in China, Europe and the United States. For more information about Lithium Werks, please visit us at www.lithiumwerks.com

Contact:
lwmarketing@lithiumwerks.com

HERE offers developers and data scientists direct access to rich geospatial data

HERE Data Layers
Precise representation of the world’s road networks, pathways, buildings, structures, places, land use and land cover.
  • Precise representation of the world’s road networks, pathways, buildings, structures, places, land use and land cover
  • Geospatial datasets for a wide range of use cases including map display, spatial analytics, business intelligence, and AI/ML analysis

September 16, 2020

Amsterdam, The Netherlands – Demand for high-quality geospatial data has skyrocketed across industries as the global economy becomes more and more digitized. HERE Technologies, the leading location data and technology platform, today released HERE Data Layers to improve software developer and data scientists’ access to the rich cartographic features and attributes captured within an enterprise-grade mapping platform.

HERE Data Layers are standalone geospatial representations of the world’s road networks, pathways, buildings, structures, places, land use and land cover. They serve as a menu for developers and data scientists to select the datasets needed to power today’s location-based functions, applications and customer experiences.

“HERE has been a leading global B2B mapmaker for decades. Today, we’re ‘disaggregating’ our map via the HERE platform to empower users across all industries to tap the value of high-quality geospatial data,” said Mithun Dhar, Vice President, Developer Relations at HERE Technologies. “We are proud to support developers and customers in achieving better outcomes, whether that’s by driving more engaging experiences, improving fleet, supply chain and road safety efficiencies, or by helping them operate more sustainably.”

The offering consists of customizable high value urban geospatial data sets in GeoJSON format and can be used in a range of use cases from map display, spatial analytics, business intelligence to AI/ML analysis.

HERE Data Layers include:

  • Administrative Divisions: (Country, State, Province, Municipality, City or Built-up Area .
  • Building: Man-made building structures with height and corresponding attribution.
  • Destination Signs: Various destinations visible on a sign and relates such destinations to a specific path in the road network.
  • Hydrography: Variety of water features (lakes, rivers, oceans, bays etc.).
  • Land Cover: Content related to land physical coverage (woodland, wetlands, grassland, desert, glacier).
  • Land Use: Content related to the functional usage of the land; it classifies areas of land for use by people.
  • Navigable Road: Road Network with topology and Navigable Attributes.
  • Places: Places and points of interest with corresponding location and related attribution.
  • Traffic Restrictions: Represents specific paths in the road network where legal, logical or physical restrictions apply.
  • Traffic Signs: Signs along the road used to inform the driver of specific road situations (e.g. Warning Signs, Priority Signs, Stop Signs).

HERE Data Layers is available for all to access via the company’s Freemium developer plan at https://developer.here.com/products/data-layers.

About HERE Technologies
HERE, a location data and technology platform, moves people, businesses and cities forward by harnessing the power of location. By leveraging our open platform, we empower our customers to achieve better outcomes – from helping a city manage its infrastructure or a business optimize its assets to guiding drivers to their destination safely. To learn more about HERE, please visit https://here.com and https://360.here.com.

Media Contact
James Overstall
+49 171 533 4418
james.overstall@here.com

Jordan Stark
+1 312 316 4537
Jordan.stark@here.com

Attachment

Vista Global and Ferrari Extend Partnership To Increase Safety for Ferrari Competizioni GT and Corse Clienti

Vista Global

Vista Global x Ferrari

  • Professional and amateur Ferrari drivers will be able to fly to the races from any country in the world with VistaJet and XO.

LE MANS, France, Sept. 16, 2020 (GLOBE NEWSWIRE) — Vista Global, the private aviation group founded by Thomas Flohr, announces it will open its global private jet fleet to all the Ferrari drivers participating in international GT races and in the Prancing Horse monobrand championships. The new service will help all Ferrari international drivers enjoy a safe and seamless flying experience with VistaJet and XO as they travel globally to compete in the races.

The Ferrari 488 GTE and 488 GT3 race in over 20 international championships all over the world, while the 488 Challenge Evo are the stars of the Ferrari Challenge series in Europe, North America and Asia. The races take place across the five continents over a 12 months’ calendar and involve hundreds of participants from around the world, including the best professional and amateur drivers.

VistaJet and XO will take care of every detail of the flights, to ensure passengers can enjoy a tailored and unparalleled service. Their award-winning safety adheres to the most rigorous standards in the world, and to safeguard passengers and crew, the group has taken additional steps to further strengthen its COVID-19 procedures on every flight.

The partnership is announced today in Le Mans, where the #54 VistaJet / XO 488 GTE participates with a team comprised of Thomas Flohr, Francesco Castellacci and Giancarlo Fisichella.

Vista Global’s Founder and Chairman, Thomas Flohr, said:
“Racing has been a passion of mine for many years. Alongside my team, I have experienced first-hand the demands of racing and the intense focus required to consistently deliver a winning performance. Vista Global is excited to be able to support all Ferrari drivers to get where they need to be, safely and in optimum condition so they can focus on what is the most important — the competition and performance on track.”

About Vista Global Holding
Vista Global Holding is the world’s first private aviation ecosystem. A global group headquartered at the DIFC in Dubai, Vista Global integrates a unique portfolio of companies offering asset-light services to cover all key aspects of business aviation: guaranteed and On Demand global flight coverage; aircraft leasing and finance; and cutting-edge aviation technology. The group’s mission is to lead the change to provide customers with the most advanced flying services and the very best value, anytime, anywhere around the world. Vista Global’s knowledge and understanding of all facets of the industry deliver the best end-to-end offering and technology to any business aviation customer, through its VistaJet and XO branded services.

Vista Global Holding Limited (“Vista Global”) does not own or operate any aircraft. All flights are performed by FAA-licensed/DOT-registered EASA or U.S. certified Vista Global group direct air carriers and/or partner operators. Vista Global holds a non-controlling minority stake in XOJET Aviation LLC.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/219a6f67-527d-480f-a05e-0df09962725e

Contact
Vista Global: press@vistaglobal.com

Philips, the Philips Foundation and Global Action Plan team up to improve the air quality at schools

September 16, 2020

  • New analysis reveals a 50% reduction in air pollution around schools across the UK and Ireland could halve the number of children who have lung function so poor as to affect their everyday lives
  • National Clean Air for Schools Framework launched to tackle air pollution in and around schools
  • Microscope images of children’s sputum reveal the level of black carbon in their lungs

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the Philips Foundation, with its mission to provide access to quality healthcare for disadvantaged communities through innovation, together with UK-based charity Global Action Plan reveal new analysis by Queen Mary University of London (QMUL) that shows if outdoor air pollution is halved, there could be up to a 20-50% reduction in the number of children with poor lung function across the UK and Republic of Ireland [1].  The analysis also finds the reduction in air pollution seen during the country-wide lockdown leads to asthma exacerbations in children all but disappearing.

Based on this analysis, a coalition comprised of Global Action Plan, the Philips Foundation, Living Streets, Modeshift Stars and Mums for Lungs, with the support of Philips and the National Association of Head Teachers (NAHT), are collaborating for nationwide action by the Government and local authorities to improve air quality at schools, driven by a legally binding target to meet World Health Organization limits.

To support the movement, Global Action Plan and the Philips Foundation, with the endorsement of Philips, have launched “The Clean Air for Schools Framework”. The framework is a free online tool that gives teachers, headteachers, parents and local authorities a bespoke blueprint of actions for tackling air pollution in and around the school. This is drawn from its database of 50 actions that have been validated by a mix of existing research, academic insights from the University of Manchester and in school air quality testing.

The tool is particularly important for schools in air pollution hotspots [2] across the UK and the Republic of Ireland.  It will enable them to reduce air pollution from their own operations, educate the next generation to help them and their families make cleaner air choices and become a local leader on air pollution, working with partners to improve air quality in the local area.

Around a quarter of all morning, rush-hour car trips during school term time comprise school run traffic, increasing emissions outside schools. A clean air program implemented by the London Borough of Hackney, pioneer of School Streets and one of the leading community grassroots initiatives proactively tackling air pollution, shows the significant improvements that can be made through these programs. The first four School Streets launched in the borough showed that traffic reduced by an average of 68%, the number of children cycling to school increased by 51%, and vehicle emissions outside schools (NOx, PM10 and PM2.5) are down by 74% as a result of the schemes [3].

“Local authorities must take advantage of free tools such as the Clean Air for Schools Framework, as the analysis by Queen Mary University of London shows, air pollution impacts the daily lives of so many children,” said Chris Large, Co-CEO at Global Action Plan. “But they must act now. Therefore, protecting today’s generation of school children against the toxins carried by air pollution is not only imperative to preventing damage to children’s daily health but also to reduce the impact of this and future pandemics.”

“As school children continue to settle into classrooms this autumn, we have a once in a generation opportunity to tackle poor air quality head-on,” said Mark Leftwich, Director Personal Health, Philips UK and Ireland. “It is vital we take immediate action to protect public health from significant future health crises, which ongoing research shows can be worsened by air pollution in a patient with underlying respiratory issues. Setting long-term targets for emissions is welcome, but we cannot wait another 20 or 30 years for proposed targets to take effect. Doing so would compromise the health of the most vulnerable communities for decades to come – which crucially includes our children.”

To demonstrate the impact air pollution has on children’s lungs, the campaign is showcasing new infra-red images of children’s sputum, which show the pollutants found in the lungs. “Airborne” by artist Sarah Stirk is a multimedia project focusing on air pollution’s impact on the health of children in London. It utilizes microscopic images of black carbon i.e., particulate matter, in children’s spit, data maps showing pollution levels and new infrared images of children. Campaigners will use the new assets as a means of making the invisible visible to put added pressure on local authorities across the UK and Ireland to take urgent action.

[1] https://www.globalactionplan.org.uk/files/effects_of_air_pollution_exposure_by_dr_abigail_whitehouse.pdf
[2] https://unearthed.greenpeace.org/2017/04/04/air-pollution-nurseries/

[3] https://news.hackney.gov.uk/traffic-to-be-banned-outside-40-schools-as-part-of-emergency-plan/

For further information, please contact:

Laura Seikritt
Philips Global Press Office
Tel.: +31 6 20 74 03 18
Email: laura.seikritt@philips.com

Elizabeth Littlewood
Philips U.K. & Ireland
Tel.: +44 7909 874563
Email: Elizabeth.littlewood@philips.com

Yannick Eshuijs
Philips Foundation
Tel.: +31 6 18 52 66 33
Email: yannick.eshuijs@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

About the Philips Foundation
The Philips Foundation is a registered charity that was established in July 2014 – founded on the belief that innovation and collaboration can help solve some of the world’s toughest healthcare challenges for the underserved and make essential impact. Reflecting our commitment to United Nations Sustainable Development Goals 3 (Ensure healthy lives and promote well-being for all at all ages) and 17 (Revitalize the global partnership for sustainable development), the mission of the Foundation is to reduce healthcare inequality by providing access to quality healthcare for disadvantaged communities. The Philips Foundation fulfills its mission by deploying Philips’ expertise, innovative products and solutions, by collaborating with key partners around the world (including respected NGOs such as UNICEF, Amref and ICRC), and by providing financial support for the collaborative activities. More information on the Philips Foundation can be found at www.philips-foundation.com

Attachments